Diagnosing hypertension: Evidence supporting the 2015 recommendations of the Canadian Hypertension Education Program

Mark Gelfer1, Martin Dawes2, Janusz Kaczorowski3

  • 1Clinical Assistant Professor in the Department of Family Practice at the University of British Columbia in Vancouver. mgelfer@telus.net.

Insights

The 2015 Canadian Hypertension Education Program (CHEP) updated guidelines recommend electronic blood pressure (BP) measurement in clinics and out-of-office BP monitoring for accurate hypertension diagnosis and improved patient management.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Clinical Practice Guidelines

Background:

  • Accurate diagnosis of hypertension is crucial for effective management.
  • Previous diagnostic methods may lead to misdiagnosis and suboptimal treatment.
  • The Canadian Hypertension Education Program (CHEP) provides annual evidence-based recommendations.

Purpose of the Study:

  • To present the 2015 CHEP recommendations for diagnosing and assessing hypertension.
  • To guide healthcare practitioners in Canada on best practices for hypertension diagnosis.
  • To improve the accuracy of hypertension diagnosis and management.

Main Methods:

  • Systematic literature search conducted by a Cochrane Collaboration librarian.
  • Critical appraisal of evidence by the CHEP subcommittee on BP measurement and diagnosis.
  • Recommendations reviewed, graded, and approved by CHEP committees and task force.
  • Evidence-based recommendations derived from Level II evidence.

Main Results:

  • Four key recommendations for 2015 to enhance BP measurement and hypertension diagnosis.
  • Strong recommendation for using electronic BP measurement devices in clinical settings.
  • Advocacy for early out-of-office BP measurement, particularly ambulatory BP monitoring, for elevated office readings.
  • Emphasis on identifying and managing white-coat hypertension.

Conclusions:

  • Enhanced diagnostic accuracy is vital for optimizing hypertension care in Canada.
  • CHEP's annual updates ensure practitioners receive current, evidence-based information.
  • Implementation of these recommendations can lead to better hypertension management outcomes.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
714
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
647
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.8K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
836